Asian Paints:2,677.80+4.01 (+0.15%)
Cipla:1,439.40-1.87 (-0.13%)
Eicher Motors:7,365.50+4.42 (+0.06%)
Nestle India:1,455.20-8.05 (-0.55%)
Grasim Inds:3,213.60+21.70 (+0.68%)
Hindalco Inds.:967.45+4.05 (+0.42%)
Hind. Unilever:2,150.60+6.00 (+0.28%)
ITC:281.75-0.31 (-0.11%)
Trent:2,902.80-1.16 (-0.04%)
Larsen & Toubro:3,945.80+59.84 (+1.54%)
M & M:3,129.40+44.12 (+1.43%)
Reliance Industries:1,307.80+28.03 (+2.19%)
Tata Consumer:1,111.90+5.20 (+0.47%)
Tata Motors PVeh:337.95+6.46 (+1.95%)
Tata Steel:191.19+3.29 (+1.75%)
Wipro:175.46+2.70 (+1.56%)
Apollo Hospitals:8,841.00-4.42 (-0.05%)
Dr Reddy's Labs:1,244.30-25.26 (-1.99%)
Titan Company:4,584.40+28.70 (+0.63%)
SBI:1,036.00+13.90 (+1.36%)
Shriram Finance:1,044.10+12.38 (+1.20%)
Bharat Electron:414.85+8.65 (+2.13%)
Kotak Mah. Bank:377.60+0.45 (+0.12%)
Infosys:1,068.00+17.23 (+1.64%)
Bajaj Finance:1,020.50+16.66 (+1.66%)
Adani Enterp.:3,157.30+73.70 (+2.39%)
Sun Pharma.Inds.:1,935.50-3.30 (-0.17%)
JSW Steel:1,245.40+19.61 (+1.60%)
HDFC Bank:824.95+7.44 (+0.91%)
TCS:2,069.00+19.47 (+0.95%)
ICICI Bank:1,401.20+20.44 (+1.48%)
Power Grid Corpn:283.10+1.74 (+0.62%)
Maruti Suzuki:13,854.00+126.29 (+0.92%)
Axis Bank:1,323.70+26.08 (+2.01%)
HCL Technologies:1,164.10+13.69 (+1.19%)
O N G C:244.96+1.32 (+0.54%)
NTPC:344.55+0.86 (+0.25%)
Coal India:429.30-0.60 (-0.14%)
Bharti Airtel:1,920.40-10.62 (-0.55%)
Tech Mahindra:1,454.80+28.53 (+2.00%)
Jio Financial:241.96+8.59 (+3.68%)
Adani Ports:1,828.10+28.08 (+1.56%)
HDFC Life Insur.:567.70+15.84 (+2.87%)
SBI Life Insuran:1,862.90+41.17 (+2.26%)
Max Healthcare:1,108.10+6.83 (+0.62%)
UltraTech Cem.:11,711.00+186.69 (+1.62%)
Bajaj Auto:10,156.00+1.02 (+0.01%)
Bajaj Finserv:1,916.00+21.03 (+1.11%)
Interglobe Aviat:5,312.00+82.62 (+1.58%)
Eternal:289.65-2.81 (-0.96%)
Asian Paints:2,677.80+4.01 (+0.15%)
Cipla:1,439.40-1.87 (-0.13%)
Eicher Motors:7,365.50+4.42 (+0.06%)
Nestle India:1,455.20-8.05 (-0.55%)
Grasim Inds:3,213.60+21.70 (+0.68%)
Hindalco Inds.:967.45+4.05 (+0.42%)
Hind. Unilever:2,150.60+6.00 (+0.28%)
ITC:281.75-0.31 (-0.11%)
Trent:2,902.80-1.16 (-0.04%)
Larsen & Toubro:3,945.80+59.84 (+1.54%)
M & M:3,129.40+44.12 (+1.43%)
Reliance Industries:1,307.80+28.03 (+2.19%)
Tata Consumer:1,111.90+5.20 (+0.47%)
Tata Motors PVeh:337.95+6.46 (+1.95%)
Tata Steel:191.19+3.29 (+1.75%)
Wipro:175.46+2.70 (+1.56%)
Apollo Hospitals:8,841.00-4.42 (-0.05%)
Dr Reddy's Labs:1,244.30-25.26 (-1.99%)
Titan Company:4,584.40+28.70 (+0.63%)
SBI:1,036.00+13.90 (+1.36%)
Shriram Finance:1,044.10+12.38 (+1.20%)
Bharat Electron:414.85+8.65 (+2.13%)
Kotak Mah. Bank:377.60+0.45 (+0.12%)
Infosys:1,068.00+17.23 (+1.64%)
Bajaj Finance:1,020.50+16.66 (+1.66%)
Adani Enterp.:3,157.30+73.70 (+2.39%)
Sun Pharma.Inds.:1,935.50-3.30 (-0.17%)
JSW Steel:1,245.40+19.61 (+1.60%)
HDFC Bank:824.95+7.44 (+0.91%)
TCS:2,069.00+19.47 (+0.95%)
ICICI Bank:1,401.20+20.44 (+1.48%)
Power Grid Corpn:283.10+1.74 (+0.62%)
Maruti Suzuki:13,854.00+126.29 (+0.92%)
Axis Bank:1,323.70+26.08 (+2.01%)
HCL Technologies:1,164.10+13.69 (+1.19%)
O N G C:244.96+1.32 (+0.54%)
NTPC:344.55+0.86 (+0.25%)
Coal India:429.30-0.60 (-0.14%)
Bharti Airtel:1,920.40-10.62 (-0.55%)
Tech Mahindra:1,454.80+28.53 (+2.00%)
Jio Financial:241.96+8.59 (+3.68%)
Adani Ports:1,828.10+28.08 (+1.56%)
HDFC Life Insur.:567.70+15.84 (+2.87%)
SBI Life Insuran:1,862.90+41.17 (+2.26%)
Max Healthcare:1,108.10+6.83 (+0.62%)
UltraTech Cem.:11,711.00+186.69 (+1.62%)
Bajaj Auto:10,156.00+1.02 (+0.01%)
Bajaj Finserv:1,916.00+21.03 (+1.11%)
Interglobe Aviat:5,312.00+82.62 (+1.58%)
Eternal:289.65-2.81 (-0.96%)
Arihant Plus App

Arihant Plus App

Medicamen Biotech Ltd

Medicamen Biotec | 531146

Live
245.35
0.05 (-0.02%)
As on 10/07/26, 7:58 PM
Market Cap332.83 CR
Current Price₹245.35
High / Low₹447.65 / 212.4
PE Ratio86.17
Book Value₹167.57
Dividend Yield0.21%
ROCE5.56%
ROE4.43%
Face Value₹2.00
Current Vol.11,149
Average Vol.---
ISININE646B01010
PB Ratio2.87
Debt to Equity0.15
Net Profit Margin4.04
Operating Margin12.72

Share Price Chart - Medicamen Biotech Ltd

+0.00 (+0.00%)6M

Stock Performance

245.4248
245.35
Previous CloseToday's Open
212.4447.65
245.35
52W Low52W High
₹248Today's Open
₹245.4Previous Close
11,149Volume
₹212.452W Low
₹447.6552W High

Ratios

No data available

About Company

  • A diversified enterprise, Medicamen Biotech Limited (MBL) is a research-led pharmaceutical company involved in developing, manufacturing and marketing of finished dosage formulations for domestic as well as international markets
  • The Company has presence over 35+ countries
  • Its offerings include Finished Dosage Forms (FDF's) to African countries
  • In India, MBL is among the leading companies in oncology segment with its own sales force and a branding team that has helped garner a strong foothold in the domestic market
  • MBL has three pharma formulation facilities including two in Haridwar (Uttarakhand), one in Bhiwadi (Rajasthan)
  • The Company manufactures products across various therapeutic categories including Pain Management, Cough & Cold, Cardiovascular & Central Nervous System, Anti-Diabetic, Gastrointestinal, Anti-Allergic among others
  • The Bhiwadi unit has ultra modern production facilities incorporating latest state of the art technology with a combination of technically qualified personnel and hardworking workforce
  • In Haridwar unit, the company manufactures Non-Betalactum preparations including tablets, capsules, oral liquids and ointments & creams
  • Medicamen Biotech Limited was incorporated in December, 1993 and started their operation as distributor and manufacturer of medicines on loan license basis
  • The distribution activities were spread manifold over a wide market extending beyond the domestic market and started exporting to CIS countries

Research Calls

Research Calls
Locked Access

Explore all active research calls & maximize your profits

To access, login or signup with ArihantPlus

Technical Indicators

RSI48.86
SMA 20239.19
SMA 50256.04
SMA 100266.47
SMA 200315.61
SMA 10249.94
MACD_12_26_Days0.29
EMA10Day248.29
EMA20Day246.66
EMA50Day253.41
MACD_12_26_9_Days2.30
EMA100Day272.74
EMA200Day308.06

Pivot Points

Volume Analysis

Delivery
Total Volume

Growth Rate

Revenue Growth-9.35%
ROE3.12%
EBITDA Margin12.72%

All figures in ₹ Crores

Indicators20252024202320222021
Revenue
162.55
179.31
140.87
115.45
112.72
Interest
3.16
4.40
2.92
1.40
1.06
Expenses
148.69
157.07
117.00
91.90
93.49
Financing Profit
20.10
24.57
26.33
25.27
19.98
Financing Margin %
12%
14%
19%
22%
18%
Other Income
6.24
2.33
2.46
1.72
0.75
Depreciation
7.07
7.09
6.37
5.77
2.52
Profit before tax
9.88
13.08
17.05
18.09
16.39
Tax %
34%
27%
14%
18%
26%
Net Profit
6.56
9.49
14.73
14.90
12.13
EPS in Rs
5.16
7.50
11.92
12.19
9.93
Show % Change
ShareHolding
📊

No Information Available

No shareholding data available at this time.

📊

No Data Available

No Block Deals data available for this company.

News

📊

No Information Available

No news available for this company.
Record Date
Corporate Action
Information
Announcement Day
26 Sept 2025
AGM
AGM
12 Aug 2025
19 Sept 2025
Final Dividend (₹1)
Financial Results year ended on 31.03.2025 the Register of Members and other Transfer books of the Company with a view to enable the Company to make payment of Final Dividend @10% or Re. 1 per Equity Share (if decided by the members in their forthcoming AGM) for the Financial year 2024-25. The aforesaid register will remain close from Friday, September 19, 2025 to Thursday September 25, 2025 (both days inclusive). (As Per BSE Announcement Dated on: 12/08/2025)
30 May 2025
26 Mar 2025
EGM
EGM
26 Feb 2025
26 Sept 2024
AGM
AGM
10 Sept 2024
19 Sept 2024
Final Dividend (₹1)
Recommended a final dividend @ 10% on Equity Shares of Rs. 10/- each i.e. Re 1/- per Equity Share for the Financial Year 2023-24. Book Closure Intimation The Company has fixed Thursday, 19th September, 2024 as the 'Record Date' for determining entitlement of members to receive final dividend for the FY 2023-24. (As per BSE Announcement Dated on 02/09/2024)
29 May 2024
27 Sept 2023
AGM
AGM
08 Aug 2023
21 Sept 2023
Final Dividend (₹1)
We wish to inform that the Board of Directors of the Company in its meeting held today i.e. May 29, 2023, which commenced at 02.30 p.m. and concluded at 04.00 p.m., inter alia, considered and approved the Audited Standalone & Consolidated Financial Results of the Company for year ended March 31, 2023 , further details attached. Outcome of the Board Meeting held on August 08, 2023 (As Per BSE Announcement dated on 08.08.2023)
29 May 2023
27 Sept 2022
AGM
AGM
10 Aug 2022
21 Sept 2022
Final Dividend (₹1)
MBL has informed BSE that the Board of Directors of the Company at its meeting held on May 25, 2022, inter alia, has considered and approved the following: - Recommendation of Dividend: Payment of final dividend @ 10% on Equity Shares of Rs. 10/- each i.e. Re 1/- per Equity Share for the Financial Year 2021-22.
25 May 2022
26 Aug 2022
EGM
EGM
01 Aug 2022

Peers

LTP(₹)
Market Cap(₹ Cr.)
P/E Ratio(Ratio)
P/B Ratio(Ratio)
Cash Earnings(Ratio)
Debt to Equity(Ratio)
Net Profit Ratio(%)
244
331
34
1
20
0
4.04%
1,935
4,64,331
37
6
30
0
19.78%
6,836
1,81,466
69
11
59
0
23.41%
4,903
1,65,952
76
20
50
1
11.09%
1,439
1,16,229
31
3
23
0
9.92%
1,151
1,14,763
21
4
17
0
19.86%
2,496
1,14,128
20
5
16
0
14.56%
2,525
1,04,275
52
6
36
0
14.39%
1,246
1,03,959
26
3
17
0
12.34%
1,565
90,875
26
2
17
0
10.98%
Showing 10 of 134 Results

Frequently Asked Questions

What is Share Price of Medicamen Biotech Ltd?

The current share price of Medicamen Biotech Ltd (Medicamen Biotec) is ₹245.35. This price reflects the latest market valuation and is updated in real-time during trading hours.

What is the P/E Ratio of Medicamen Biotech Ltd?

The Price-to-Earnings (P/E) ratio of Medicamen Biotech Ltd is 245.35. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.

What is the 52-week high and low of Medicamen Biotech Ltd?

Medicamen Biotech Ltd has a 52-week high of ₹447.65 and a 52-week low of ₹212.40. This range shows the stock's price volatility over the past year.

What is the Dividend Yield of Medicamen Biotech Ltd?

Medicamen Biotech Ltd offers a dividend yield of 0.41%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.

What is the EPS of Medicamen Biotech Ltd?

The Earnings Per Share (EPS) of Medicamen Biotech Ltd is ₹7.11. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.

What is the ROE of Medicamen Biotech Ltd?

Medicamen Biotech Ltd has a Return on Equity (ROE) of 4.43%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.

Disclaimer:

Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.

mobile

Ready to invest smarter?
Download the app today.

GET IT ON

GET IT ON

Google Play

4.5

DOWNLOAD ON THE

DOWNLOAD ON THE

App Store

4.2